PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
68.88%
Positive growth while VET shows revenue decline. John Neff would investigate competitive advantages.
10.94%
Cost increase while VET reduces costs. John Neff would investigate competitive disadvantage.
144.69%
Positive growth while VET shows decline. John Neff would investigate competitive advantages.
44.89%
Margin expansion while VET shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
2038.10%
G&A growth above 1.5x VET's 0.63%. Michael Burry would check for operational inefficiency.
No Data
No Data available this quarter, please select a different quarter.
1300.00%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
159.58%
Operating expenses growth above 1.5x VET's 7.87%. Michael Burry would check for inefficiency.
42.59%
Total costs growth above 1.5x VET's 0.53%. Michael Burry would check for inefficiency.
-1.03%
Interest expense reduction while VET shows 4.24% growth. Joel Greenblatt would examine advantage.
-4.81%
D&A reduction while VET shows 12.77% growth. Joel Greenblatt would examine efficiency.
101.86%
EBITDA growth while VET declines. John Neff would investigate advantages.
-17.51%
Both companies show margin pressure. Martin Whitman would check industry conditions.
2810.71%
Operating income growth while VET declines. John Neff would investigate advantages.
1705.10%
Operating margin growth while VET declines. John Neff would investigate advantages.
-395.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
925.00%
Pre-tax income growth while VET declines. John Neff would investigate advantages.
588.51%
Pre-tax margin growth while VET declines. John Neff would investigate advantages.
325.81%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
7116.67%
Net income growth while VET declines. John Neff would investigate advantages.
4254.78%
Net margin growth while VET declines. John Neff would investigate advantages.
7112.99%
EPS growth while VET declines. John Neff would investigate advantages.
7236.56%
Diluted EPS growth while VET declines. John Neff would investigate advantages.
0.04%
Share count reduction exceeding 1.5x VET's 0.38%. David Dodd would verify capital allocation.
-1.80%
Diluted share reduction while VET shows 0.00% change. Joel Greenblatt would examine strategy.